Today's Date: December 20, 2014 Search | Home | Contact | Services | Patent Attorney | Patent Search | Provisional Patent Application | Patent Application | Software Patent | Confidentiality Agreements

Bilski

Missed Opportunities for Alice, Software at the Supreme Court

Posted: Monday, Mar 31, 2014 @ 6:45 pm | Written by Gene Quinn | 19 comments
| Tags: , , , , , , , , , , , , , , , ,
Posted in: Bilski, Business Methods, Computers, Gene Quinn, Government, IP News, IPWatchdog.com Articles, Patentability, Patents, Software, Technology & Innovation, US Supreme Court

Justice Antonin Scalia, who seemed most favorable to Alice.

Once Chief Justice John Roberts said “[t]he case is submitted,” which occurred this morning at 11:05 a.m., the reading of the tea leaves began.

The Supreme Court was very hot Court, with a lot of questions on the mind of the Justices. After reviewing the transcript I am left believing the Court is likely wondering whether it is possible to find the Alice patent claims to be patent ineligible while also ruling that software patent claims are not all patent ineligible. Surprisingly, it seemed as if Justice Scalia was most persuaded by the patent eligibility of the claims, directly saying at one point that the issues circling the case seem to really be about 102, not 101.

While I support the patent eligibility of the patent claims, particularly the patent claims drawn to a system, it seems undeniable that Alice missed many opportunities to score easy points. Indirect arguments were made by Alice that didn’t seem very persuasive. Indeed, if one is to predict the outcome of the case based on oral arguments alone it did not go well for Alice today. Only three things give Alice supporters hope after this oral argument as far as I can tell. First, the government seems to be asking the Supreme Court to overrule precedent in Bilski that is not even four years old, which simply isn’t going to happen. Second, the egregious overreach and outright misleading nature of the CLS Bank argument should raise a legitimate question or two in the mind of the Justices.  Third, the reality simply is that at least the systems claims recite numerous specific, tangible elements such that it should be impossible to in any intellectually honest way find those claims to cover an abstract idea.



Patent Turmoil: Navigating the Software Patent Quagmire

Posted: Monday, Jul 15, 2013 @ 8:00 am | Written by Gene Quinn | 39 comments
| Tags: , , , , , , , , , , , , , , , , , , ,
Posted in: Bilski, Computers, Federal Circuit, Gene Quinn, IP News, IPWatchdog.com Articles, Patent Prosecution, Patent Trial and Appeal Board, Patents, Software, Software Patent Basics, US Supreme Court, USPTO

The law as it relates to software has been in flux over the last 10 years. Many older patent applications simply do not have enough detail to satisfy the current requirements to obtain a patent, although when drafted they would have been sufficient to satisfy the requirements then in place. Describing software as a pure method claim has not worked for a long time despite the fact that in reality software is really a method. Much more than a cursory description of software as a series of steps is required in order to have hope of obtaining patent protection for software.

Indeed, ever since the Federal Circuit en banc decision in Bilski, claims have been required to be tethered to tangible components, such as data storage devices, processors, databases, controllers, servers and the like. Unfortunately, however, the Patent Trial and Appeals Board at the United States Patent and Trademark Office now has taken the position that they will ignore the tangible components within a computer implemented method claim and then look to see what remains before determining whether the claim is patent eligible. See PTAB Kills Software.

Of course, after you remove or ignore the tangible components what remains is a naked process, which is patent ineligible. Thus, deciding to ignore tangible components leads to the inescapable conclusion that no software is patent eligible. Such disingenuous reasoning has the effect of punishing applicants for writing claims as the Patent Office has mandated ever since the machine-or-transformation test was first announced by the Federal Circuit in Bilski. The test announced in SAP/Versata, which was the first covered business method review decision announced by the PTAB, cannot be the correct test, and ultimately the decision (or at least the rationale) will be reversed. Any test that has the net effect of rendering all software patent ineligible, like the SAP/Versata test, is simply not correct as I will explain more clearly below.



CLS Bank International: A Fractured Landscape of Patent Eligibility for Business Methods and Systems*

Posted: Thursday, Jul 12, 2012 @ 7:30 am | Written by Eric Guttag | 28 comments
| Tags: , , , , , , , , , , , ,
Posted in: Authors, Bilski, Business Methods, Computers, Eric Guttag, Federal Circuit, IP News, IPWatchdog.com Articles, Patentability, Patents

After the Supreme Court ruled in Bilski v. Kappos that a claimed method for managing (hedging) the risks associated with trading commodities at a fixed price was patent-ineligible under 35 U.S.C. § 101, the Federal Circuit has gone “hither and yonder” in trying to determine when other business methods and systems reach (or don’t reach) the patent-eligibility zone.  At the patent-ineligible end is CyberSource Corporations v. Retail Decisions, Inc. where Judge Dyk (joined by Judges Bryson and Prost) ruled that a method and system for detecting credit card fraud in Internet transactions was patent-ineligible under 35 U.S.C. § 101.  At the patent-eligible end is Ultramercial, LLC v. Hulu, LLC (recently vacated and remanded by the Supreme Court for reconsideration by the Federal Circuit) where Chief Judge Rader (joined by Judges Lourie and O’Malley) ruled that a claimed method for monetizing and distributing copyrighted products over the Internet was patent-eligible.  See Throwing Down the Gauntlet: Rader Rules in Utramercial that Breadth and Lack Specificity Does Not Make Claimed Method Impermissibly Abstract.

These polar opposite decisions in CyberSource and Ultramercial illustrate how fractured the Federal Circuit’s patent-eligibility landscape has now become for business methods and systems.  The most recent split decision in CLS Bank International v. Alice Corp. Pty. Ltd. where a claimed trading platform for exchanging business obligations survived a validity challenge under 35 U.S.C. § 101 epitomizes this problem.  As CLS Bank International unfortunately shows, an objective standard for judging the patent-eligibility of business methods and systems remains elusive, subject to an ever growing “tug-of-war” between the “inclusive” and “restrictive” patent-eligibility factions of the Federal Circuit.  In particular, after CLS Bank International, we are no closer to having a judicially accepted definition of what is (or is not) an “abstract idea” when it comes to claiming business methods and systems.



Patenting Business Methods and Software in the U.S.

Posted: Monday, Jul 18, 2011 @ 4:21 pm | Written by Gene Quinn | 3 comments
| Tags: , , , , , , , , , , , , , , , ,
Posted in: Bilski, Business Methods, Computers, Gene Quinn, IP News, IPWatchdog.com Articles, Patent Drafting, Patent Drafting Basics, Patentability, Patents, Software, Software Patent Basics

A little over a year ago the United States Supreme Court issued its decision in Bilski v. Kappos. The critical question presented to the Court for consideration was whether the Federal Circuit erred by creating the so-called “machine or transformation” test, which requires a process to be tied to a particular machine or apparatus, or transform an article into a different state or thing, in order to be patentable subject matter. The Supreme Court held that the machine-or-transformation test is not the sole test for patent eligibility under §101, but rather that it was an important clue, thereby overruling the Federal Circuit who had earlier ruled that the machine or transformation test was the singular test to determine whether an invention is patentable subject matter.

But what practical effect did the Supreme Court ruling in Bilski v. Kappos have? Truthfully, not much at least in terms of the day to day approach of patent attorneys and the U.S. Patent and Trademark Office.  Certainly, the decision was important in that it preserved the patentability of at least some business methods and preserved the patentability of software, both of which continue to remain patentable in the United States.  What has transpired since the Supreme Court’s decision, however, is not much different, if at all different, than what happened day-to-day prior to the decision.



One Year Post-Bilski: How the Decision is Being Interpreted

Posted: Wednesday, Jun 29, 2011 @ 5:27 pm | Written by Michelle Holoubek | 6 comments
| Tags: , , , , , , ,
Posted in: Authors, Bilski, IP News, IPWatchdog.com Articles, Patent Trial and Appeal Board, Patentability, Patents, USPTO

Justice Kennedy delivered the opinion of the Court in Bilski v. Kappos.

This week marks the first anniversary of the Supreme Court issuing its decision in Bilski v. Kappos. The decision held that the machine-or-transformation test is not the exclusive test for patent eligibility, and that the three traditional exclusions of natural phenomena, abstract ideas, and laws of nature still apply.

Since that time, 182 decisions involving statutory subject matter eligibility have been issued by the USPTO’s Board of Patent Appeals and Interferences (“the Board”). District Courts issued 6 decisions in the past year that substantively addressed statutory subject matter under § 101, while the Federal Circuit issued 3 decisions on the subject. The day after Bilski issued, the Supreme Court denied cert in In re Ferguson, and just recently picked up Mayo Collaborative Servs. v. Prometheus Labs for review.  See Supreme Court Accepts Appeal on Patented Medical Diagnostics.



Supreme Court Accepts Appeal on Patented Medical Diagnostics

Posted: Monday, Jun 20, 2011 @ 1:08 pm | Written by Gene Quinn | 5 comments
| Tags: , , , , , , , , , , , , ,
Posted in: Bilski, Gene Quinn, IP News, IPWatchdog.com Articles, Medical Devices & Methods, Patents, US Supreme Court

U.S. Supreme Court Building, Washington, D.C.

Earlier today the United States Supreme Court granted certiorari in Mayo Collaborative Services v. Prometheus Laboratories, Inc., which sets up another foray into the patent eligible subject matter waters for the Supreme Court in the October 2011 term.  This appeal by Mayo will challenge the December 17, 2010 decision of the United States Court of Appeals for the Federal Circuit, one of the first patentable subject matter cases for the Federal Circuit in the wake of the Supreme Court’s decision in Bilski v. Kappos.  In fact, this case was returned from the Supreme Court to the Federal Circuit for further consideration in light of the Supreme Court ruling in Bilski v. Kappos.



Why Bilski Re-Affirms the Patent-Eligibility of Software

Posted: Thursday, Aug 5, 2010 @ 12:33 pm | Written by Robert Plotkin | 42 comments
| Tags: , , , , , , , , , ,
Posted in: Authors, Bilski, Computers, IP News, IPWatchdog.com Articles, Patentability, Patents, Software

Although much remains unclear after the U.S. Supreme Court’s decision in Bilski v. Kappos, one thing is certain: software remains patent-eligible in the U.S. This result may not be entirely clear from a quick read of the opinions in the case. Therefore, I present the following pieces of evidence that the Supreme Court in Bilski effectively re-affirmed the patent-eligibility of software (listed, for the sake of simplicity, in the order in which they appear in the decision).



Jumping Down the Rabbit Hole: Federal Circuit Ducks the Patent-Eligibility Issue in King Pharmaceuticals

Posted: Tuesday, Aug 3, 2010 @ 11:50 pm | Written by Eric Guttag | 10 comments
| Tags: , , , , , , , , , , , , , , , , , , , , , , , ,
Posted in: Bilski, Business Methods, Federal Circuit, IP News, IPWatchdog.com Articles, Patent Litigation, Patentability, Patents

As Alice once said things are growing “curioser and curioser.”  I just opined about the “fuzzy” looking glass called Bilski v. Kappos for determining what is (or remains) patent-eligible subject matter under 35 U.S.C. § 101.  See Through the Fuzzy Bilski Looking Glass: The Meaning of Patent-Eligible under 35 U.S.C. § 101 .  After reading King Pharmaceuticals, Inc. v. Eon Labs, Inc., I’m now ready to throw my Ouija board though that Bilski looking glass.  With an opportunity to render some order out of the Bilski chaos, the Federal Circuit instead completely ducked the patent-eligibility issue clearly presented in King Pharmaceuticals.  The Federal Circuit then created (and I do mean “created”) the new “an anticipated method claim doesn’t become patentable if it simply includes an informing step about an inherent property of that method” doctrine.  With this new “doctrine,” we have now “jumped down the rabbit hole” into a surreal “Bilski in Patentland” world.



Interview Finale: Chief Judge Michel on Bilski & Supreme Court

Posted: Tuesday, Aug 3, 2010 @ 10:03 am | Written by Gene Quinn | 2 comments
| Tags: , , , , , , , ,
Posted in: Bilski, Gene Quinn, Interviews & Conversations, IP News, IPWatchdog.com Articles, Patents, US Supreme Court

Chief Judge Paul Michel (ret.)

In this final installment of my interview with Chief Judge Paul Michel we discuss Bilski v. Kappos and what he thought of the Supreme Court’s decision. Judge Michel talks about how only one of the Justices who decided Bilski ever decided a patentable subject matter decision, leaving the impression that the Supreme Court should probably just leave well enough alone. He tells us that he “think[s] the Federal Circuit can help minimize harm” that may otherwise be caused by the Supreme Court’s decision in Bilski v. Kappos, but is unsure whether the Federal Circuit can all “the harm that may lie inherent in the approach of the Supreme Court in that opinion…” Chief Judge Michel also discusses how he feels that the patent system is now favoring extremely large companies over independent inventors, start-ups and small businesses. Plus, the fun stuff!



Patent Office Releases Interim Bilski Guidelines

Posted: Tuesday, Jul 27, 2010 @ 11:21 am | Written by Gene Quinn | 16 comments
| Tags: , , , , , , , , , , , , ,
Posted in: Bilski, Business Methods, Gene Quinn, IP News, IPWatchdog.com Articles, Patentability, Patents, USPTO

This morning the United States Patent and Trademark Office published Interim Guidance for Determining Subject Matter Eligibility for Process Claims in View of Bilski v. Kappos. The Interim Bilski Guidance is effective July 27, 2010, and applies to all applications filed before, on or after the effective date. Most noteworthy is that the Patent Office is encouraging examiners to issue 101 rejection in only “extreme cases” and allow patentability to be decided by sections 102, 103 and 112.

These interim guidelines build upon the memo sent to the examining corps the day the Supreme Court issued its decision in Bilski v. Kappos, and is intended for use by Office personnel when determining subject matter eligibility under 35 U.S.C. 101. According to the Federal Register Notice, this guidance supersedes previous guidance on subject matter eligibility that conflicts with the Interim Bilski Guidance.



Through the Fuzzy Bilski Looking Glass: The Meaning of Patent-Eligible under 35 U.S.C. § 101

Posted: Thursday, Jul 22, 2010 @ 6:38 pm | Written by Eric Guttag | 74 comments
| Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , ,
Posted in: Authors, Bilski, Biotechnology, Business Methods, Computers, Eric Guttag, Federal Circuit, IP News, IPWatchdog.com Articles, Patentability, Patents, Software, US Supreme Court, USPTO

Alice enters another world through the looking glass

In Chapter 6 of Lewis Carroll’s Through the Looking Glass, Humpty Dumpty tells Alice scornfully “when I use a word, it means just what I choose it to mean – neither more nor less.”  After reading and compositing the various opinions by the nine SCOTUS Justices in USPTO v. Bilski, I, like many others, are still wondering what is a patent-ineligible “abstract idea” (other than Bilski’s claimed method for instructing buyers and sellers how to protect against the risk of price fluctuations in a discrete section of the economy, i.e., hedge against such risks) and especially what does “patent-eligible” really mean under 35 U.S.C. § 101.  The composite opinions by SCOTUS in Bilski concoct a standard for patent-eligibility that is as fuzzy and circular as the logic Humpty Dumpty employed on Alice.

As you might imagine, there are many takes on what the SCOTUS Bilski ruling actually says, including mine.  See Section 273 is NOT a Red Herring: Stevens’ Disingenuous Concurrence in Bilski where I waxed lyrical about now retired Justice Stevens’ disingenuous sophistry in his concurrence which treats 35 U.S.C. § 273 as if it didn’t exist, but which is, in fact, an implicit, if not explicit, recognition and acceptance by Congress that “business methods” (however you characterize them) ARE patent-eligible subject matter under 35 U.S.C. § 101.  See also Foaming at the Mouth III: And Then Came Bilski where I commented on the most recent “thunderbolt” from our Judicial Mount Olympus as SCOTUS summarily granted certiorari in Prometheus Laboratories, Inc. v. Mayo Collaborative Services and Classen Immunotherapies, Inc. v. Biogen Idec, and then vacated and remanded both cases to the Federal Circuit to reconsider (with equally “fuzzy” guidance) in light of SCOTUS’ ruling in Bilski.



Foaming at the Mouth III: And Then Came Bilski

Posted: Wednesday, Jul 7, 2010 @ 3:48 pm | Written by Eric Guttag | 29 comments
| Tags: , , , , , , , , , , , , , , , ,
Posted in: Bilski, Biotechnology, Business Methods, Federal Circuit, Gene Patents, IP News, IPWatchdog.com Articles, Patentability, Patents, US Economy

When I wrote my first “Foaming at the Mouth” article (see Foaming at the Mouth: The Inane Ruling in the Gene Patents Case) on Association for Molecular Pathology v. USPTO (hereinafter AMP, but also known as “the gene patent case” or “the Myriad case” or “ACLU v. Myriad”), I never expected it to become a sequel.  But Judge Sweet’s inane 152-page ruling on the ACLU challenge to the Myriad patents was soon to be followed by the new and equally inane Becerra Bill by Congressman Xavier Becerra (D-California, aka “The Gene Patent Terminator”) that would plunge us into an “anti-gene patenting hell” with the potential to destroy American biotech industry.  See Foaming at the Mouth II: My Alternative to the New But Inane Becerra Bill .  And then came the U.S. Supreme Court ruling last week in Bilski v. Kappos.  See Section 273 is NOT a Red Herring: Stevens’ Disingenuous Concurrence in Bilski where I “foamed” on and waxed lyrical about now retired Justice Stevens’ disingenuous sophistry in his concurrence.

One reason I was quite interested in Bilski was because the Supreme Court (not surprisingly) ruled that the Federal Circuit’s “machine or transformation” test was too inflexible, much like the “teaching, suggestion and motivation” (TSM) test in KSR International v. Teleflex. So why my intense interest in the Supreme Court (aka the Judicial Mount Olympus) relegating the “machine or transformation” (aka MoT) test to “second class status” in Bilski?  Besides the inanity of MoT as the sole test for patent-eligibility, I am interested because of Judge Sweet’s ill-advised reliance on MoT (now smitten by the thunderbolts from our Judicial Mount Olympus in Bilski) for invalidating Myriad’s method claims using its BRCA1 and BRCA2 gene sequence technology.